Preparation of Valsartan

A technology of valsartan and valine methyl ester, applied in the field of drug synthesis, to achieve the effect of safe operation

Inactive Publication Date: 2011-05-11
江苏德峰药业有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No need to directly use biphenyl derivatives as raw materials for synthesis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of Valsartan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] step a

[0021] Preparation of N-[(4-bromo)-benzylidene]-L-valine methyl ester

[0022] Add 16ml of triethylamine to 14g, 0.082mol of L-valine methyl ester hydrochloride in 120ml of tetrahydrofuran, then add 15g of anhydrous magnesium sulfate, and after fully stirring the reaction, add 9.7g, 0.064mol of p-bromobenzene Formaldehyde, after the reaction was complete, the two phases were separated, the liquid phase was evaporated in vacuo and dried in high vacuum to give a pale yellow oil. It was directly put into the next reaction without further treatment.

[0023] step b

[0024] Preparation of N-[(4-bromo)-benzyl]-L-valine methyl ester

[0025] The oil was dissolved in 150 ml of dry methanol. Cool the solution to 0°C, then slowly add sodium borohydride for one hour with stirring until the reaction of the imine is complete, add 40ml of water to the solution, evaporate the solution in a vacuum, add 700ml of water and 100ml of dihydrogen to the remaining liquid Chloro...

Embodiment 2

[0036] step a

[0037] Preparation of N-[(4-bromo)-benzylidene]-L-valine methyl ester

[0038] Add 16ml of triethylamine to 15g of L-valine tert-butyl ester hydrochloride, 0.082mol in 120ml of dichloromethane, then add 20g of anhydrous magnesium sulfate, after fully stirring the reaction, add 9.7g, 0.064mol of p-Bromobenzaldehyde, after the reaction is complete, the two phases are separated, the liquid phase is evaporated in vacuo and dried in high vacuum to give a pale yellow oil.

[0039] It was directly put into the next reaction without further treatment.

[0040] step b

[0041] Preparation of N-[(4-bromo)-benzyl]-L-valine tert-butyl ester

[0042] Dissolve the oil in 180ml of anhydrous methanol, cool the solution to 0°C, then slowly add sodium borohydride with stirring, and finish adding within one hour until the reaction of the imine is complete, add 40ml of water to the solution, and dissolve the solution Evaporate in vacuo, add 700ml of water and 100ml of dichloro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel method for preparing valsartan, which comprises the steps: taking L-valine methyl ester or L-valine methyl ester hydrochloride and p-bromobenzaldehyde as raw materials, carrying out reductive amination and acidylation reaction to obtain an intermediate, and performing SUZUKI reaction on the intermediate so as to obtain the valsartan. The method is safely operated, and avoids a step of tetrazole synthesis, and azide and other explosible hazardous compounds are not necessarily used; and the used raw materials can be easily obtained, and most of the raw materials are conventional chemical raw materials. In the method, biphenyl derivatives are not required for preparing the valsartan, and biphenyl products are obtained mainly through the suzuki reaction.

Description

technical field [0001] The present invention belongs to medicine synthesis. It specifically relates to a new preparation method of valsartan, namely its intermediate N-pentanoyl-N-[[2'-(N'-trityl-tetrazol-5-yl)-(1,1'- The preparation method of diphenyl)-4-yl]-methyl]-L-valine methyl ester. Background technique [0002] Valsartan is a popular non-peptide angiotensin Ⅱ (AT Ⅱ) receptor antagonist. The chemical name of valsartan is N-valeryl-N-[[2'-tetrazolium- 5-yl)-(1,1'-diphenyl)-4-yl]-methyl]-L-valine. [0003] The key of existing valsartan and intermediate synthesis methods is tetrazole formation and biphenylation reaction. [0004] The classic synthesis of valsartan patent US 5399578 is based on the synthesis of 2'-cyano-4-formylbiphenyl as a raw material, which is condensed with protected L-valine to form a Schiff base, and then reduced by alkali metal borohydride. N-valerylation reaction, into tetrazole, deprotection to get valsartan. [0005] Among them, tetrazole ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D257/04
Inventor 王德峰俞健钧
Owner 江苏德峰药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap